SCHEMBL5541390

SCHEMBL5541390

Oc1cccc2c1C=CCO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.42
CYP1A2 P05177 7/20 0.40
CYP1A1 P04798 6/20 0.40
CYP1B1 Q16678 6/20 0.40
MTNR1A P48039 2/20 0.38
MTNR1B P49286 1/20 0.38
CA1 P00915 2/20 0.32
CA9 Q16790 1/20 0.32
ADAMTS4 O75173 1/20 0.32
ALDH1A1 P00352 1/20 0.32
EGFR P00533 1/20 0.32
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.32
FYN P06241 1/20 0.32
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
MMP8 P22894 1/20 0.32
CA6 P23280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275271 0.76 CYP2B6 (0.46) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
SCHEMBL2008458 0.76 CYP2B6 (0.42) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
SCHEMBL14653042 0.76 CYP2B6 (0.42) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
SCHEMBL8215841 0.76 CYP1A2 (0.46) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
SCHEMBL5541990 0.76 CYP2B6 (0.46) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
Hydrochloric Acid SCHEMBL29164105 0.74 CYP2B6 (0.41) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
SCHEMBL1338706 0.74 CYP2B6 (0.42) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
Pyrogallol SCHEMBL10388757 0.74 RECQL (0.41) CYP2B6CYP1A2CYP1A1CYP1B1CA1
SCHEMBL13113614 0.73 CYP2B6 (0.43) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A
SCHEMBL30291346 0.73 CYP2B6 (0.43) CYP2B6CYP1A2CYP1A1CYP1B1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
CN-116218033-A Application of organic material in preparing color-changeable polymer material 四川大学 2023-06-06 CN claimed
EP-3793517-A1 PHARMACEUTICAL FORMULATION Klaria Pharma Holding AB (SE) 2021-03-24 EP claimed
WO-2020037532-A1 BIFIDOBACTERIUM BREVE CCFM1025, FOODS FERMENTED THEREBY AND APPLICATION THEREOF 江南大学 2020-02-27 WO claimed
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 US disclosed
CN-116218033-B Application of organic material in preparing color-changeable polymer material 四川大学 2025-03-14 CN disclosed
US-11993562-B2 Methods for isolation and purification of cannabidiol (CBD) and terpenes from hemp RJ LEE GROUP, INC. (US) 2024-05-28 US disclosed
CN-114031595-B Photochromic compound and application thereof 江苏视科新材料股份有限公司 2024-01-26 CN disclosed
US-20230295067-A1 METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF REAL ISOLATES, LLC 2023-09-21 US disclosed
EP-4229190-A1 BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS Ginkgo Bioworks, Inc. (US) 2023-08-23 EP disclosed
CN-111094234-B Organic compound and organic electroluminescent element comprising same 材料科学有限公司 2023-08-22 CN disclosed
CN-114031597-B Polysubstituted dibenzochromene compound and application thereof 江苏视科新材料股份有限公司 2023-08-01 CN disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed
US-5919954-A CYCLIZATION OF CHEMICAL INTERMEDIATES; HIGH ENANTIOMORPHIC PURITY ELI LILLY AND COMPANY (US) 1999-07-06 US disclosed
US-5795886-A ANTICONVULSANTS ELI LILLY AND COMPANY (US) 1998-08-18 US disclosed
EP-0021827-B1 POLYALKYLHYDROXYCHROMENE AND PROCESS FOR PREPARING THE SAME MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1983-05-11 EP disclosed
US-4323505-A HERBICIDES, FUNGICIDES MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1982-04-06 US disclosed
EP-0021827-A1 Polyalkylhydroxychromene and process for preparing the same MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1981-01-07 EP disclosed
US-3947462-A 2,4,7-substituted 5-hydroxy benzopyrans and esters ABBOTT LABORATORIES (US) 1976-03-30 US disclosed
US-3855229-A BENZOPYRAN-5-OLS THOMPSON W 1974-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11993562-B2 Methods for isolation and purification of cannabidiol (CBD) and terpenes from hemp CNR2, CNR1, CYP8B1 CYP2B6 754/4885CYP1A2 457/4885CYP1A1 1384/4885
US-20230295067-A1 METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF MYCBP, MAX, ABCG2 CYP2B6 2255/4885CYP1A2 1627/4885CYP1A1 1765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.